Skip to main content

Table 2 Comparison of in vitro drug susceptibility profiles between M. intracellulare and M. avium isolates

From: Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016

Antimicrobial agents No. of resistant isolates (%) P value
M. avium
(n = 95)
M. intracellulare
(n = 159)
Clarithromycin 4 (4.2) 6 (3.8) 1.000
Moxifloxacin 5 (5.3) 8 (5.0) 1.000
Linezolid 11 (11.6) 13 (8.2) 0.370
  1. The breakpoints to establish susceptibility and resistance for clarithromycin, moxifloxacin and linezolid were followed as recommendation from Clinical and Laboratory Standards Institute (CLSI-M24-A2)